Literature DB >> 24784706

Cardioprotective effects of thyroid hormones in a rat model of myocardial infarction are associated with oxidative stress reduction.

Alexandre Luz de Castro1, Angela Vicente Tavares1, Cristina Campos1, Rafael Oliveira Fernandes1, Rafaela Siqueira1, Adriana Conzatti1, Amanda M Bicca1, Tânia Regina G Fernandes1, Carmem L Sartório1, Paulo Cavalheiro Schenkel2, Adriane Belló-Klein1, Alex Sander da Rosa Araujo3.   

Abstract

Reactive oxygen species (ROS) are involved with progression from infarction to heart failure. Studies show that thyroid hormones (TH) present cardioprotective effects. This study aims to evaluate whether TH effects after infarction are associated to redox balance modulation. Male Wistar rats were divided into four groups: Sham-operated (SHAM), infarcted (AMI), sham-operated+TH (SHAMT), and infarcted+TH (AMIT). During 26 days, animals received T3 (2 μg/100g/day) and T4 (8 μg/100g/day) by gavage. Echocardiographic parameters were assessed and heart tissue was collected to biochemical analysis. AMIT rats presented absence of lung congestion, less cardiac dilatation, and normalization in myocardial performance index, compared with AMI. AMI rats presented an increase in hydrogen peroxide levels and in lipid peroxidation and a decrease in GSH/GSSG. TH prevented these alterations in AMIT. In conclusion, TH seem to reduce the levels of ROS, preventing oxidative stress, and improving cardiac function in infarcted rats.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Reactive oxygen species; Redox balance; T3; T4

Mesh:

Substances:

Year:  2014        PMID: 24784706     DOI: 10.1016/j.mce.2014.04.010

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

1.  T3 and T4 decrease ROS levels and increase endothelial nitric oxide synthase expression in the myocardium of infarcted rats.

Authors:  Alexandre Luz de Castro; Angela Vicente Tavares; Rafael Oliveira Fernandes; Cristina Campos; Adriana Conzatti; Rafaela Siqueira; Tânia Regina G Fernandes; Paulo Cavalheiro Schenkel; Carmem L Sartório; Susana Llesuy; Adriane Belló-Klein; Alex Sander da Rosa Araujo
Journal:  Mol Cell Biochem       Date:  2015-07-10       Impact factor: 3.396

Review 2.  Effects of bioactive compounds from Pleurotus mushrooms on COVID-19 risk factors associated with the cardiovascular system.

Authors:  Eduardo Echer Dos Reis; Paulo Cavalheiro Schenkel; Marli Camassola
Journal:  J Integr Med       Date:  2022-07-11

3.  Hypothyroidism is associated with clinical outcomes in patients with acute myocardial infarction: subgroup analysis of China PEACE study.

Authors:  Wenyao Wang; Siyuan Wang; Kuo Zhang; Jing Chen; Xuan Zhang; Chunli Shao; Ping Li; Yi-Da Tang
Journal:  Endocrine       Date:  2021-06-03       Impact factor: 3.633

Review 4.  Mitochondria as key targets of cardioprotection in cardiac ischemic disease: role of thyroid hormone triiodothyronine.

Authors:  Francesca Forini; Giuseppina Nicolini; Giorgio Iervasi
Journal:  Int J Mol Sci       Date:  2015-03-19       Impact factor: 5.923

5.  Free Triiodothyronine Level Correlates with Myocardial Injury and Prognosis in Idiopathic Dilated Cardiomyopathy: Evidence from Cardiac MRI and SPECT/PET Imaging.

Authors:  Wenyao Wang; Haixia Guan; Wei Fang; Kuo Zhang; A Martin Gerdes; Giorgio Iervasi; Yi-Da Tang
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

6.  Association between Low Free Triiodothyronine Levels and Poor Prognosis in Patients with Acute ST-Elevation Myocardial Infarction.

Authors:  Yuanbin Song; Jiabei Li; Shizhu Bian; Zhexue Qin; Yaoming Song; Jun Jin; Xiaohui Zhao; Mingbao Song; Jianfei Chen; Lan Huang
Journal:  Biomed Res Int       Date:  2018-04-16       Impact factor: 3.411

Review 7.  The impact of thyroid hormone dysfunction on ischemic heart disease.

Authors:  Madalena von Hafe; João Sergio Neves; Catarina Vale; Marta Borges-Canha; Adelino Leite-Moreira
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

8.  Management of Hypothyroidism in Patients with Acute Myocardial Infarction.

Authors:  Danielle Eagan; Gabriela Spencer-Bonilla; Spyridoula Maraka; Monica Aggarwal; Naykky Singh Ospina
Journal:  Medicina (Kaunas)       Date:  2020-04-28       Impact factor: 2.430

Review 9.  Prospective role of thyroid disorders in monitoring COVID-19 pandemic.

Authors:  Kanchan Kumari; Gagan B N Chainy; Umakanta Subudhi
Journal:  Heliyon       Date:  2020-12-13

10.  Pterostilbene Reduces Experimental Myocardial Infarction-Induced Oxidative Stress in Lung and Right Ventricle.

Authors:  Silvio Tasca; Cristina Campos; Denise Lacerda; Vanessa D Ortiz; Patrick Turck; Sara E Bianchi; Alexandre L de Castro; Adriane Belló-Klein; Valquiria Bassani; Alex Sander da Rosa Araújo
Journal:  Arq Bras Cardiol       Date:  2022-02       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.